Effect of 300- and 450-mg clopidogrel loading doses on membrane and soluble P-selectin in patients undergoing coronary stent implantation

American Heart Journal

Volumn 143, Issue 1, 2002, Pages 118-123

  Seyfarth, Hans Juergen ^a   Koksch, Mario ^a   Roethig, Gerd ^a   Rother, Traugott ^a   Neugebauer, Annerose ^a   Klein, Norbert ^a   Pfeiffer, Dietrich ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DIPHOSPHATE; CLOPIDOGREL; PADGEM PROTEIN;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY STENT; DOSE RESPONSE; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMAN; IMPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; THROMBOCYTE AGGREGATION INHIBITION; THROMBOSIS;

EID: 0036141127     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1067/mhj.2002.119372     Document Type: Article

References (31)

1. Coronary stent placement in patients with acute myocardial infarction: Comparison of clinical and angiographic outcome after randomization to antiplatelet or anticoagulant therapy
2. A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents
3. Clinical and angiographic results from the stent anticoagulation regimen study (STARS)
4. The thienopyridine PCR 4099 selectively inhibits ADP-induced platelet aggregation and fibrinogen binding without modifying the membrane glycoprotein IIb-IIIa complex in rat and in man
5. Clopidogrel, a novel antiplatelet and antithrombotic agent
6. Inhibitory effect of clopidogrel on platelet adhesion and intimal proliferation after arterial injury in rabbits
7. Clopidogrel instead of ticlopidine after coronary stent placement: Is the switch justified?
8. Clopidogrel-a platelet inhibitor which inhibits thrombogenesis in non-anticoagulated human blood independently of the blood flow conditions
9. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)
10. The CAPRIE trial: Culmination of the preregistration program for clopidogrel
11. Clopidogrel versus ticlopidine after intracoronary stent placement
12. Double-blind study of the safety of clopidogrel with and without a loading dose in combination with aspirin compared with ticlopidine in combination with aspirin after coronary stenting: The Clopidogrel Aspirin Stent International Cooperative Study (CLASSICS)
13. Combination therapy with clopidogrel and aspirin after coronary stenting
14. Clopidogrel for prevention of major cardiac events after coronary stent implantation: 30-day and 6-month results in patients with smaller stents
15. Hemolytic uremic syndrome associated with clopidogrel
16. Effectiveness of clopidogrel and aspirin versus ticlopidine and aspirin in preventing stent thrombosis after coronary stent implantation
17. Early potent antithrombotic effect with combined aspirin and a loading dose of clopidogrel on experimental arterial thrombogenesis in humans
18. Clopidogrel inhibition of stent, graft, and vascular thrombogenesis with antithrombotic enhancement by aspirin in nonhuman primates
19. Single-dose pharmacodynamics of copidogrel
20. Repeated-dose pharmacodynamics of clopidogrel in healthy subjects
21. Clopidogrel loading dose regimens: Kinetic profile of pharmacodynamic response in healthy subjects
22. Reduction in major adverse cardiac events, including mortality, after stenting using clopidogrel instead of ticlopidine
23. ADP-anatgonists therapy added to aspirin prior to coronary intervention markedly attenuates the risk associated with baseline CRP status
24. Evaluation of platelet function by flow cytometry
25. Role of soluble and platelet-bound P-selectin in discriminating cardiac from noncardiac chest pain at presentation in the emergency department
26. Characterization of GMP-140 (P-selectin) as circulating plasma protein
27. Soluble P-selectin is not surrogate marker for platelet P-selectin: Evidence from a multicenter chest pain study group
28. Rapid onset of inhibition of ADP-induced platelet aggregation by a loading dose of clopidogrel
29. Clopidogrel
30. Pharmacokinetics of clopidagrel
31. 14C-labeled clopidogrel